A Phase I, Open-label to the Route of Administration, Single-blind to the Intradermal (ID) Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart Intradermal Suspension for Injection (Influenza Vaccine, Whole-virion, Inactivated, Adjuvanted) in Adult Subjects

Trial Profile

A Phase I, Open-label to the Route of Administration, Single-blind to the Intradermal (ID) Doses, Randomised, Active-controlled, Parallel Study to Evaluate the Safe Usability of 4Fluart Intradermal Suspension for Injection (Influenza Vaccine, Whole-virion, Inactivated, Adjuvanted) in Adult Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2018

At a glance

  • Drugs Quadrivalent-inactivated-influenza-vaccine-Fluart-Innovative-Vaccines (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Fluart Innovative Vaccines
  • Most Recent Events

    • 08 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top